Lung cancer is the second most frequent cause of cancer and a leading cause of death worldwide accounting 20% of all cancer-related deaths, and it is estimated to increase 45–90% by 2030. Despite the introduction of screening programs and new therapeutic strategies (i.e. targeted therapy) for specific subgroups of patients, the estimated 5-year survival rate is only 12%. Early detection and prompt intervention are crucial to improving the outcome of these patients.
New Perspective in Lung Cancer Diagnosis
Elisa Baratella
Primo
2024-01-01
Abstract
Lung cancer is the second most frequent cause of cancer and a leading cause of death worldwide accounting 20% of all cancer-related deaths, and it is estimated to increase 45–90% by 2030. Despite the introduction of screening programs and new therapeutic strategies (i.e. targeted therapy) for specific subgroups of patients, the estimated 5-year survival rate is only 12%. Early detection and prompt intervention are crucial to improving the outcome of these patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1076633224008547-main.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
83.79 kB
Formato
Adobe PDF
|
83.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
